In a murine xenograft model using the cell line KYSE-410 or H358, the combination of adagrasib and the SHP2 inhibitor RMC-4550 resulted in a statistically significant reduction in tumor growth [32]. The gene discussed is PTPN11; the disease is neoplasm.